Connor, Clark & Lunn Investment Management (CC&L)’s Gossamer Bio GOSS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-126,233
| Closed | -$151K | – | 1424 |
|
|
2023
Q2 | $151K | Sell |
126,233
-139,411
| -52% | -$167K | ﹤0.01% | 1220 |
|
|
2023
Q1 | $335K | Buy |
+265,644
| New | +$335K | ﹤0.01% | 987 |
|
|
2022
Q4 | – | Sell |
-121,546
| Closed | -$1.46M | – | 1299 |
|
|
2022
Q3 | $1.46M | Buy |
121,546
+64,179
| +112% | +$769K | 0.01% | 568 |
|
|
2022
Q2 | $480K | Buy |
57,367
+12,113
| +27% | +$101K | ﹤0.01% | 792 |
|
|
2022
Q1 | $393K | Sell |
45,254
-465
| -1% | -$4.04K | ﹤0.01% | 825 |
|
|
2021
Q4 | $517K | Sell |
45,719
-787
| -2% | -$8.9K | ﹤0.01% | 793 |
|
|
2021
Q3 | $585K | Buy |
+46,506
| New | +$585K | ﹤0.01% | 742 |
|